Grifols (NASDAQ:GRFS) has commenced discussions with banks to refinance its bonds due in 2025, Bloomberg News reported, a day ...

For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...

The embattled Spanish drugmaker Grifols SA is in talks with banks to refinance about €1.4 billion ($1.48 billion) in bonds ...

Grifols rejects Brookfield’s €10.5/share offer, signaling undervaluation. Read why GRFS stock is a strong "Buy" despite the ...

Canadian fund Brookfield said on Wednesday it has dropped its plan to take over Spain's Grifols due to a disagreement over ...

基立福（Grifols）近日在西班牙的股票交易中遭遇重创，股价跌幅扩大至10%，刷新了每日最低记录。这一显著下滑反映出投资者对该公司前景的忧虑，尤其是在当前全球医药市场愈发动荡的背景下。

Grifols ends acquisition talks with Brookfield over valuation concerns, highlights strong revenue growth and financial ...

Canadian investment fund Brookfield said Wednesday it has dropped its bid for Spanish pharmaceutical firm Grifols following ...

With Spanish plasma specialist Grifols turning down a potential multi-billion-dollar takeover bid, it’s likely back to the ...

周二，德意志银行的一位分析师更新了盖立复（Grifols SA）（GRF:SM）（OTC: GIFOF）的目标价，将其从此前的€9.00上调至€10.00，同时维持对该股的"持有"评级。此次调整是在公司于2024年11月7日公布第三季度业绩后做出的。 分析师指出，对模型的调整较小，盖立复的整体前景保持不变。与同行相比，盖立复的股票正在以折价交易，尽管考虑到公司的债务负担，其EV/EBITDA比率的 ...

Grifols SA’s board of directors said it won’t recommend that shareholders accept Brookfield Asset Management’s indicative ...

The Board of Directors of Grifols (GRFS) announced the termination of discussions with Brookfield Capital Partners UK regarding a ...